Foghorn Therapeutics Stock Price History
| FHTX Stock | USD 4.12 0.32 7.21% |
Below is the normalized historical share price chart for Foghorn Therapeutics extending back to October 23, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Foghorn Therapeutics stands at 4.12, as last reported on the 21st of March, with the highest price reaching 4.12 and the lowest price hitting 4.12 during the day.
If you're considering investing in Foghorn Stock, it is important to understand the factors that can impact its price. Foghorn Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0371, which denotes the company had a -0.0371 % return per unit of risk over the last 3 months. Foghorn Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Foghorn Therapeutics' Standard Deviation of 5.02, variance of 25.18, and Mean Deviation of 3.78 to check the risk estimate we provide.
At this time, Foghorn Therapeutics' Liabilities And Stockholders Equity is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 108.6 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (43.3 M). . Price Earnings To Growth Ratio is likely to rise to 0.1 in 2025, whereas Price To Sales Ratio is likely to drop 10.89 in 2025. Foghorn Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of October 2020 | 200 Day MA 6.4294 | 50 Day MA 4.6584 | Beta 3.131 |
Foghorn |
Sharpe Ratio = -0.0371
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FHTX |
Estimated Market Risk
| 4.91 actual daily | 43 57% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Foghorn Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Foghorn Therapeutics by adding Foghorn Therapeutics to a well-diversified portfolio.
Price Book 10.707 | Enterprise Value Ebitda (1.21) | Price Sales 10.9246 | Shares Float 25.8 M | Wall Street Target Price 11.5 |
Foghorn Therapeutics Stock Price History Chart
There are several ways to analyze Foghorn Stock price data. The simplest method is using a basic Foghorn candlestick price chart, which shows Foghorn Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 13, 2025 | 6.16 |
| Lowest Price | January 29, 2025 | 3.98 |
Foghorn Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Foghorn Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Foghorn Stock. It can be used to describe the percentage change in the price of Foghorn Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Foghorn Stock.| Foghorn Therapeutics Price Action Indicator | (0.16) | |
| Foghorn Therapeutics Price Rate Of Daily Change | 0.93 |
Foghorn Therapeutics March 21, 2025 Stock Price Analysis
Foghorn Stock Price History Data
The price series of Foghorn Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 2.28 with a coefficient of variation of 12.31. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.8. The median price for the last 90 days is 4.65.| Open | High | Low | Close | Volume | ||
03/21/2025 | 4.44 | 4.12 | 4.12 | 4.12 | ||
| 03/20/2025 | 4.37 | 4.53 | 4.11 | 4.12 | 157,482 | |
| 03/19/2025 | 4.47 | 4.60 | 4.25 | 4.44 | 101,952 | |
| 03/18/2025 | 4.52 | 4.67 | 4.40 | 4.44 | 85,842 | |
| 03/17/2025 | 4.42 | 4.71 | 4.41 | 4.60 | 105,128 | |
| 03/14/2025 | 4.57 | 4.73 | 4.39 | 4.43 | 44,979 | |
| 03/13/2025 | 4.56 | 4.67 | 4.38 | 4.48 | 64,020 | |
| 03/12/2025 | 4.52 | 4.90 | 4.43 | 4.58 | 98,035 | |
| 03/11/2025 | 4.45 | 4.48 | 4.11 | 4.44 | 106,632 | |
| 03/10/2025 | 4.35 | 4.54 | 4.22 | 4.40 | 106,597 | |
| 03/07/2025 | 4.45 | 4.80 | 4.40 | 4.52 | 74,243 | |
| 03/06/2025 | 4.64 | 4.70 | 4.42 | 4.50 | 60,344 | |
| 03/05/2025 | 4.36 | 4.78 | 4.30 | 4.67 | 91,507 | |
| 03/04/2025 | 4.25 | 4.52 | 4.05 | 4.39 | 93,916 | |
| 03/03/2025 | 4.86 | 4.86 | 4.26 | 4.32 | 116,480 | |
| 02/28/2025 | 4.61 | 4.93 | 4.55 | 4.85 | 102,315 | |
| 02/27/2025 | 5.00 | 5.21 | 4.63 | 4.63 | 108,857 | |
| 02/26/2025 | 5.09 | 5.28 | 4.97 | 5.01 | 154,442 | |
| 02/25/2025 | 5.13 | 5.35 | 4.94 | 5.10 | 184,390 | |
| 02/24/2025 | 5.30 | 5.48 | 5.02 | 5.16 | 152,296 | |
| 02/21/2025 | 5.43 | 5.54 | 5.08 | 5.23 | 183,495 | |
| 02/20/2025 | 5.77 | 6.27 | 5.36 | 5.38 | 173,069 | |
| 02/19/2025 | 5.98 | 6.12 | 5.68 | 5.87 | 139,710 | |
| 02/18/2025 | 6.41 | 6.66 | 5.82 | 5.96 | 210,841 | |
| 02/14/2025 | 6.21 | 6.50 | 6.01 | 6.13 | 179,196 | |
| 02/13/2025 | 5.66 | 6.31 | 5.41 | 6.16 | 206,348 | |
| 02/12/2025 | 5.32 | 5.72 | 5.32 | 5.52 | 125,996 | |
| 02/11/2025 | 5.27 | 5.49 | 5.11 | 5.37 | 255,543 | |
| 02/10/2025 | 5.45 | 6.19 | 5.08 | 5.29 | 572,399 | |
| 02/07/2025 | 4.11 | 4.77 | 4.09 | 4.75 | 243,253 | |
| 02/06/2025 | 4.39 | 4.56 | 4.08 | 4.12 | 81,911 | |
| 02/05/2025 | 3.96 | 4.51 | 3.96 | 4.37 | 111,781 | |
| 02/04/2025 | 3.92 | 4.26 | 3.90 | 4.11 | 113,026 | |
| 02/03/2025 | 4.01 | 4.22 | 3.89 | 3.98 | 95,068 | |
| 01/31/2025 | 4.40 | 4.64 | 4.05 | 4.19 | 118,325 | |
| 01/30/2025 | 4.17 | 4.46 | 4.05 | 4.34 | 82,312 | |
| 01/29/2025 | 4.10 | 4.10 | 3.86 | 3.98 | 75,771 | |
| 01/28/2025 | 4.10 | 4.21 | 4.01 | 4.10 | 87,983 | |
| 01/27/2025 | 3.98 | 4.39 | 3.97 | 4.12 | 84,634 | |
| 01/24/2025 | 4.36 | 4.43 | 3.92 | 4.06 | 122,148 | |
| 01/23/2025 | 4.32 | 4.48 | 4.24 | 4.38 | 61,829 | |
| 01/22/2025 | 4.40 | 4.45 | 4.19 | 4.37 | 91,784 | |
| 01/21/2025 | 4.33 | 4.52 | 4.17 | 4.41 | 114,952 | |
| 01/17/2025 | 4.27 | 4.44 | 4.16 | 4.31 | 73,413 | |
| 01/16/2025 | 4.41 | 4.46 | 4.16 | 4.20 | 94,786 | |
| 01/15/2025 | 4.45 | 4.47 | 4.14 | 4.35 | 68,293 | |
| 01/14/2025 | 4.43 | 4.46 | 4.13 | 4.24 | 85,067 | |
| 01/13/2025 | 4.21 | 4.42 | 4.16 | 4.37 | 214,390 | |
| 01/10/2025 | 4.67 | 4.91 | 4.17 | 4.30 | 179,180 | |
| 01/08/2025 | 4.68 | 4.79 | 4.63 | 4.65 | 90,366 | |
| 01/07/2025 | 4.61 | 4.99 | 4.60 | 4.69 | 211,394 | |
| 01/06/2025 | 4.93 | 5.04 | 4.65 | 4.66 | 196,877 | |
| 01/03/2025 | 4.65 | 4.86 | 4.55 | 4.80 | 256,290 | |
| 01/02/2025 | 4.81 | 5.00 | 4.54 | 4.59 | 124,992 | |
| 12/31/2024 | 4.66 | 4.85 | 4.55 | 4.72 | 144,816 | |
| 12/30/2024 | 4.75 | 4.75 | 4.46 | 4.61 | 178,360 | |
| 12/27/2024 | 5.09 | 5.22 | 4.65 | 4.82 | 204,490 | |
| 12/26/2024 | 4.93 | 5.17 | 4.90 | 5.09 | 127,984 | |
| 12/24/2024 | 4.94 | 5.04 | 4.82 | 5.02 | 47,593 | |
| 12/23/2024 | 5.15 | 5.34 | 4.91 | 4.93 | 142,437 | |
| 12/20/2024 | 4.93 | 5.28 | 4.88 | 5.14 | 443,756 |
About Foghorn Therapeutics Stock history
Foghorn Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Foghorn is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Foghorn Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Foghorn Therapeutics stock prices may prove useful in developing a viable investing in Foghorn Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54.9 M | 42.3 M | |
| Net Loss | -98 M | -102.9 M |
Foghorn Therapeutics Stock Technical Analysis
Foghorn Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Foghorn Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Foghorn Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Foghorn Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Foghorn to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | 0.0174 | |||
| Treynor Ratio | 0.8252 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Foghorn Stock Analysis
When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.